Acelyrin Raises $540M IPO; Shares Shut Up 30% on First Day of Buying and selling
Woodland Hills-based Acelyrn Inc., which is creating immunology medicine, raised no less than $540 million in an preliminary public providing on the Nasdaq market on Could 5 Buying and selling below the image SLRN, Acelyrin provided 30 million shares at $18 per share. On the shut of buying and selling on Could 5, the share … [Read more…]